1998
DOI: 10.2807/esm.03.12.00112-en
|View full text |Cite
|
Sign up to set email alerts
|

ESEN: a comparison of vaccination programmes – Part three : measles mumps and rubella

Abstract: Cet article est le dernier d’une série de trois articles portant sur la comparaison, dans huit pays (Danemark, Angleterre et Pays de Galles, Finlande, France, Allemagne, Italie, Suède et Pays-Bas), des programmes vaccinaux et de l’impact épidémiologique d

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
3

Year Published

1999
1999
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 4 publications
0
17
0
3
Order By: Relevance
“…mass campaigns in the United Kingdom and the Americas, multidose regimes in the United States and Scandinavia), several authors [9][10][11][12] have stressed the need for all EU countries to increase coverage to target levels of 95 % as recommended in the ' Health for all in the year 2000 ' programme of WHO Europe. The epidemic we have reported is therefore further evidence that vaccination levels of 70-75 % are insufficient to prevent outbreaks, especially in school settings.…”
Section: Discussionmentioning
confidence: 99%
“…mass campaigns in the United Kingdom and the Americas, multidose regimes in the United States and Scandinavia), several authors [9][10][11][12] have stressed the need for all EU countries to increase coverage to target levels of 95 % as recommended in the ' Health for all in the year 2000 ' programme of WHO Europe. The epidemic we have reported is therefore further evidence that vaccination levels of 70-75 % are insufficient to prevent outbreaks, especially in school settings.…”
Section: Discussionmentioning
confidence: 99%
“…These discrepancies in incidence of disease between countries with similar vaccine coverage may be due to different histories of immunization programmes. However, the use of surveillance data for either setting targets or to compare disease epidemiology between different countries is fraught with difficulties [11]. For example, in France, unlike other countries, the mumps incidence data is extrapolated to account for the incompleteness of mumps notifications [34].…”
Section: Discussionmentioning
confidence: 99%
“…Some of these results have previously been reported [11]. On the basis of mean reported vaccine coverage for mumps vaccine in the 3 years prior to the collection of the main serum banks, countries were divided into high (vaccine coverage >90%), medium (vaccine coverage 80-90%) and low coverage countries (<80 %).…”
Section: Vaccine Programme Structure and Coveragementioning
confidence: 99%
“…The disease usually occurs among children and in the prevaccine era, the annual reported mumps incidences in Western European countries ranged between 100 and 600 per 100,000 inhabitants [3]. With the availability of a live-attenuated mumps vaccine since the 1960s [4], disease incidence dramatically decreased in countries with mumps vaccination programmes [5,6].…”
Section: Introductionmentioning
confidence: 99%